AzTrials
AzTrials

Meniscus; DegenerationNCT05233839

Efficacy of Telerehabilitation in Patients With Degenerative Meniscal Injury

A study testing Telerehabilitation and Paper Based Rehabilitation in people with Meniscus; Degeneration, run by Muğla Sıtkı Koçman University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of the study is to compare the home exercise program performed with video-based telerehabilitation in patients with degenerative meniscal injury, and the home exercise program performed with one-on-one training in the hospital with conventional methods. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Meniscus; Degeneration
What is being tested?
Telerehabilitation and Paper Based Rehabilitation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
49 participants
Where
1 siteTurkey (Türkiye)
Study dates
15 Mar 2022to 15 Jul 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Male and female patients aged 18 - 65 years
  • Having been diagnosed with degenerative meniscus injury by an orthopedist by MRI examination
  • Having signed the consent form

Who cannot join

  • Situations that will prevent assessments or communication with the individual
  • Having an operation due to degenerative meniscus injury problem
  • Orthopedic and neurological problems that would prevent evaluation and/or treatment

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Muğla Sıtkı Koçman Training and Research Hospital

    Muğla, Menteşe, 48000

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Telerehabilitation and Conventional Rehabilitation on Clinical Outcomes and Exercise Compliance in Patients With Degenerative Meniscal Injury

The aim of the study is to compare the home exercise program performed with video-based telerehabilitation in patients with degenerative meniscal injury, and the home exercise program performed with one-on-one training in the hospital with conventional methods.

Read the detailed description

Conventional rehabilitation (CR) practices will be applied to the first study group. Telerehabilitation (TR) application will be applied to the second study group. It is aimed to evaluate the patients in terms of pain, functionality, quality of life and exercise compliance.

Being tested
Telerehabilitation, Paper Based Rehabilitation
Keywords
Degenerative meniscus injury, Telerehabilitation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • TelerehabilitationOther

    Application based video home exercise for the degenerative meniscus injury

  • Paper Based RehabilitationOther

    Paper instruction based home exercise for the degenerative meniscus injury

Study groups in NCT05233839
Study groupRoleWhat they receive
Telerehabilitation (TR)ExperimentalThe TR group will be followed up through the application within the 8-week home exercise program.
Receives: Other: Telerehabilitation
Paper Based Rehabilitation (PBR)Active comparatorThe PBR group will be followed up through the paper instruction within the 8-week home exercise program.
Receives: Other: Paper Based Rehabilitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual Analog Scale (VAS)

    On a 10 cm straight line or numerical scale (0: no pain, 10: unbearable pain).

    Measured: Change from Baseline VAS at 8 weeks

  2. Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)

    WOMAC consists of 3 main headings: pain intensity, stiffness, and physical function. The total score ranges from 0 (no disability) to 96 (complete disability).

    Measured: Change from Baseline WOMAC at 8 weeks

  3. SF-12

    SF 12 is a self-evaluation scale. It consists of seven items. Its score ranged from 0 to 100, with higher scores indicating better physical and mental health functioning.

    Measured: Change from Baseline SF-12 at 8 weeks

  4. Muscle Strength Test with Lafayette Hand Held Dynamometer

    It is an objective muscle strength measurement tool. Measurements are made 3 times. A rest of 120 seconds is given between measurements. The highest measured value is noted.

    Measured: Change from Baseline Dynamometer Value at 8 weeks

  5. Proprioception Measurement with Baseline Bubble Inclinometer

    The "absolute angle difference", which is the difference between the targeted angle and the angle realized by the patient in each repetition, is recorded. The arithmetic mean of the absolute angle difference of 3 repetitions is the result data.

    Measured: Change from Baseline Inclinometer Value at 8 weeks

Secondary outcomes (2)
  1. EARS

    In order to observe the individual's adaptation to exercise, the motivation levels of the patients regarding the exercise program are evaluated with the exercise diary prepared by the researchers of the study. It is scored between 0 to 24. Higher scores indicate greater adherence.

    Measured: Change from Baseline EARS at 8 weeks

  2. TSUQ

    It consists of 21 items. With this survey, the satisfaction levels and usability of individuals using the telemedicine service are evaluated. The total score is scored between 17 and 85. Higher scores indicate higher satisfaction and usability.

    Measured: Change from Baseline TSUQ at 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Feb 2022
  2. Study start15 Mar 2022
  3. Primary completion30 Jun 2022
  4. Study completion15 Jul 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomised controlled trial
Masking
None (open label)
Enrolment
49 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05233839
Sponsor's protocol ID
Mugla
Status last verified
Aug 2022
First submitted
13 Jan 2022
Last updated
1 Sep 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Telerehabilitation and Paper Based Rehabilitation in people with Meniscus; Degeneration, run by Muğla Sıtkı Koçman University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Sep 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual Analog Scale (VAS) (time frame: Change from Baseline VAS at 8 weeks). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Sep 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in